Latest: FDA Approves New Biosimilar for Oncology Treatment

Capturing a contradiction: T cells and the benign-to-malignant transition

0 Mins
Peter Westcott runs an independent research group at Cold Spring Harbor Laboratory (NY, USA), which is interested in how cancer interacts with the immune system and other normal cells in the surrounding tissue, and how these interactions change throughout critical stages and transitions in cancer development. His group uses a combination of innovative mouse models […] The post Capturing a contradiction: T cells and the benign-to-malignant transition appeared first on BioTechniques.
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago